EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Integrated Role of Cardiac Magnetic Resonance and Genetics in Predicting Left Ventricular Reverse Remodelling in Dilated and Non-Dilated Cardiomyopathy

Martina Setti, Manuela Iseppi, Job A J Verdonschot, Jacopo G Rizzi, Alessia Paldino, Carola Pio Loco Detto Gava, Giulia Barbati, Matteo Dal Ferro, Max F G H M Venner, Anne G Raafs, Marta Gigli, Davide Stolfo und 10 weitere

European Journal of Heart Failure · 01.11.2025 · 27 (11) · 2571-2581

DOI: 10.1002/ejhf.3671 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, online erschienen am 29.04.2025. Verfasst von Martina Setti und 21 weiteren Autor:innen. Beteiligte Einrichtung: Center for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), …. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Cine, Ventricular Remodeling, Cardiomyopathy, Dilated, Ventricular Function, Left. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Left ventricular reverse remodelling (LVRR) is a prognostic marker in patients with dilated (DCM) and non-dilated left ventricular cardiomyopathy (NDLVC). The utility of combining late gadolinium enhancement (LGE) and genetic testing in predicting LVRR in DCM/NDLVC remains a knowledge gap. This study aimed to assess an integrated approach including LGE data and genetics to predict LVRR in DCM/NDLVC patients. Methods and results This multicentre observational study included DCM/NDLVC patients with: (i) baseline echocardiographic left ventricular ejection fraction (LVEF) <50%; (ii) genetic testing; (iii) baseline cardiac magnetic resonance (CMR); (iv) 12-month follow-up echocardiographic data. LVRR was defined as LVEF increase ≥10% or LVEF ≥50% (if baseline LVEF <45%) at 12 months. Outcome measures were: (i) all-cause mortality, heart transplant, or left ventricular assist device implantation (D/HT/LVAD); (ii) sudden cardiac death or major ventricular arrhythmias (SCD/MVA). Arrhythmogenic genes studied were LMNA, DSP, FLNC, and RBM20. Among 1757 DCM/NDLVC with genetic data, 616 met eligibility (462 DCM, 154 NDLVC; age 51 ± 14 years, 34% female). LVRR occurred in 314 patients (51%): 251 (54%) in DCM and 63 (41%) in NDLVC (p = 0.004). Independent predictors of LVRR within 1 year included titin truncating variants, absence of arrhythmogenic genes, and absence of LGE ring-like pattern. In patients with LVEF <35%, only the presence of LGE ring-like pattern and arrhythmogenic genes remained independently related to a lower rate of LVRR and increased SCD/MVA risk.

Conclusion

In a large genetically and CMR characterized DCM/NDLVC cohort, arrhythmogenic genotypes and LGE ring-like pattern were inversely related to LVRR, particularly in patients with LVEF <35%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance Imaging, CineVentricular RemodelingCardiomyopathy, DilatedVentricular Function, LeftHeart VentriclesHumansFemaleMaleMiddle AgedStroke VolumeGenetic TestingEchocardiographyPrognosisAdultFollow-Up Studies

Stichwörter der Autor:innen

Arrhythmogenic genesCardiac magnetic resonanceDilated cardiomyopathyLeft ventricular reverse remodellingNon dilated left ventricular cardiomyopathyRing‐like late gadolinium enhancement

Autor:innen und Institutionen

  • Center for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart).
  • Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.
  • Division of Cardiology, Ospedale Santa Chiara, Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento, Trento, Italy.
  • Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
  • Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.

Zitieren

APA

Setti, M., Iseppi, M., Verdonschot, J. A. J., Rizzi, J. G., Paldino, A., Pio Loco Detto Gava, C., Barbati, G., Dal Ferro, M., Venner, M. F. G. H. M., Raafs, A. G., Gigli, M., Stolfo, D., De Luca, A., De Angelis, G., Capovilla, T. M., Graw, S., Ribichini, F. L., Taylor, M., Mestroni, L., …, & Merlo, M. (2025). Integrated Role of Cardiac Magnetic Resonance and Genetics in Predicting Left Ventricular Reverse Remodelling in Dilated and Non-Dilated Cardiomyopathy. European Journal of Heart Failure, 27(11), 2571-2581. https://doi.org/10.1002/ejhf.3671

Vancouver

Setti M, Iseppi M, Verdonschot JAJ, Rizzi JG, Paldino A, Pio Loco Detto Gava C, et al. Integrated Role of Cardiac Magnetic Resonance and Genetics in Predicting Left Ventricular Reverse Remodelling in Dilated and Non-Dilated Cardiomyopathy. European Journal of Heart Failure. 2025;27(11):2571-2581. doi:10.1002/ejhf.3671

BibTeX
@article{Setti2025,
  author = {Setti, Martina and Iseppi, Manuela and Verdonschot, Job A J and Rizzi, Jacopo G and Paldino, Alessia and Pio Loco Detto Gava, Carola and Barbati, Giulia and Dal Ferro, Matteo and Venner, Max F G H M and Raafs, Anne G and Gigli, Marta and Stolfo, Davide and De Luca, Antonio and De Angelis, Giulia and Capovilla, Teresa M and Graw, Sharon and Ribichini, Flavio L and Taylor, Matthew and Mestroni, Luisa and Heymans, Stephane R B and Sinagra, Gianfranco and Merlo, Marco},
  title = {Integrated Role of Cardiac Magnetic Resonance and Genetics in Predicting Left Ventricular Reverse Remodelling in Dilated and Non-Dilated Cardiomyopathy},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {11},
  pages = {2571--2581},
  doi = {10.1002/ejhf.3671}
}
Kostenlos starten →